NLPB News
- National Drug Schedules: Final Recommendations for Brimonidine Tartrate Ophthalmic Solution in Concentrations up to and Including 0.025% - November 15th, 2022
- PostScript – Issue 87 - October 24th, 2022
- Fall 2022 issue of The Apothecary now available! - September 27th, 2022
- COVID-19 Guidance for Pharmacy Professionals - September 26th, 2022
The guidance provided on this page is intended to support pharmacy professionals with information and advice for providing pharmacy services during the COVID-19 pandemic. This page will be updated as required. Please click the link below to bring you to the appropriate section: Provincial and National COVID-19 Information Pages Reducing Risk Within the Pharmacy Environment…
- NLPB Appoints New Registrar and CEO - September 12th, 2022
Noelle Patten appointed as the next Registrar and CEO of the Newfoundland and Labrador Pharmacy Board. We are pleased to announce Noelle Patten’s appointment to the position of Registrar and CEO of the Newfoundland and Labrador Pharmacy Board (NLPB). Ms. Patten’s appointment follows an extensive recruitment process to find a leader with a strategic vision…
- PostScript – Issue 86 - September 1st, 2022
- National Drug Schedules: Final Recommendations for topical diclofenac diethylamine - August 3rd, 2022
- Call for Expression of Interest – MedSTEP NL Taskforce - July 8th, 2022
NLPB is currently seeking pharmacists and pharmacy technicians to join the MedSTEP NL Taskforce. This is an exciting opportunity to impact the quality and safety of pharmacy practice in the province. Upon the adoption, in principle, of the National Association of Pharmacy Regulatory Authorities (NAPRA) Model Standards for Continuous Quality Improvement and Medication Incident Reporting at NLPB’s…
